People

Joël Eyer

Joël Eyer is an Inserm research director and neuroscience researcher specializing in neuronal cytoskeleton, peptides and glioblastoma. He co-founded GlioCure in September2016 with Claire Lépinoux-Chambaud and Louis-Marie Bachelot; his research team discovered the NFL-TBS.40-63 peptide underlying GC01. Own2017 and2020 announcements named him a scientific adviser, while the current public advisory directory names four other experts. Founding and historical advisory affiliations are retained without inventing current employee status.